Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries
PaperCitations, authors & open-access status
Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 129 citations, 2014 year and bronze oa status.
129
Citations
2014
Year
bronze
OA Status